Citation: M. Welcker et al., P21(WAF1 CIP2) MUTANTS DEFICIENT IN INHIBITING CYCLIN-DEPENDENT KINASES (CDKS) CAN PROMOTE ASSEMBLY OF ACTIVE CYCLIN-D CDK4(6) COMPLEXES INHUMAN TUMOR-CELLS/, Cancer research, 58(22), 1998, pp. 5053-5056
Citation: M. Welcker et al., ENHANCED PROTEIN STABILITY - A NOVEL MECHANISM OF D-TYPE CYCLIN OVER-ABUNDANCE IDENTIFIED IN HUMAN SARCOMA-CELLS, Oncogene, 13(2), 1996, pp. 419-425
Authors:
LUKAS J
BARTKOVA J
WELCKER M
PETERSEN OW
PETERS G
STRAUSS M
BARTEK J
Citation: J. Lukas et al., CYCLIN D2 IS A MODERATELY OSCILLATING NUCLEOPROTEIN REQUIRED FOR G1 PHASE PROGRESSION IN SPECIFIC CELL-TYPES, Oncogene, 10(11), 1995, pp. 2125-2134
Citation: M. Mogk et al., CASE-REPORT - THERAPY OF ANTIGLOMERULAR B ASEMENT-MEMBRANE DISEASE WITH IMMUNOADSORPTION, Immunitat und Infektion, 23(5), 1995, pp. 187-189
Citation: M. Welcker et K. Helmke, THERAPY OF AUTOIMMUNE NEPHROTIC GLOMERULO PATHIES BY COMBINED IMMUNOADSORPTION AND IVIG THERAPY, Immunitat und Infektion, 23(4), 1995, pp. 140-141